Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
biotech
boston blog main
boston top stories
life sciences
national blog main
clinical trials
new york blog main
san francisco blog main
europe blog main
fda
national top stories
new york top stories
san francisco top stories
startups
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biology
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
codiak biosciences
community oncology alliance
cutaneous t-cell lymphoma
cvs health
deciphera pharmaceuticals
deerfield management
What
medicines
5
×
new
5
×
ipo
based
cancer
companies
developing
activity
addition
aim
alltrna
announced
approvals
begin
betting
bio
biogen
biosciences
biotech
bio’s
black
boost
brings
bubbles
called
cells
change
clamped
class
clinic
clinical
codiak
community
company
covid
curious
delays
diagnostics
diamond
diseases
Language
unset
Current search:
new
×
medicines
×
cancer
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
